Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment
- PMID: 33986033
- PMCID: PMC8120138
- DOI: 10.1183/13993003.01033-2021
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment
Abstract
There is a high prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission despite a low level of clinical suspicion
Conflict of interest statement
Conflict of interest: M. Jevnikar has nothing to disclose. Conflict of interest: O. Sanchez reports personal fees and non-financial support from BTG, grants and personal fees from Boston Scientific, grants, personal fees and non-financial support from Bayer and BMS, personal fees from Sanofi Aventis, grants from Daiichi Sankyo, during the conduct of the study; grants, personal fees and non-financial support from MSD, grants from Boehringer Ingelheim, outside the submitted work. Conflict of interest: M. Humbert reports grants and personal fees from Actelion, personal fees from GSK and Merck, outside the submitted work. Conflict of interest: F. Parent has nothing to disclose.
Comment on
-
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission.Eur Respir J. 2021 Jul 20;58(1):2100116. doi: 10.1183/13993003.00116-2021. Print 2021 Jul. Eur Respir J. 2021. PMID: 33692122 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical